-Mone Zaidi Researcher Activity Profile

Research Author Detailed Information 

Mone Zaidi Publication Rate By Year

Mone Zaidi has published 30 paper(s) in 2007, 7 paper(s) in 2008, for a total of 37 research publications in total.

Mone M Zaidi Author Information

LAST NAME: zaidi

FIRST NAME: Mone

INITIALS: m

AFFILIATION:

Papers

Mone Zaidi's Publication Record

1. CD38 is required for priming by TNF-alpha: a mechanism for extracellular coordination of cell fate. Year Published: 2007
Mount Sinai Bone Program, Mount Sinai School of Medicine, Box 1055, 1 Gustave Levy Place, New York, NY 10029, USA.
2. Osteoclastic differentiation and function regulated by old and new pathways. Year Published: 2007
Department of Pathology, University of Pittsburgh and Veterans' Affairs Health System, Pittsburgh, PA 15261, USA. hcblair@imap.pitt.edu
3. Evidence that calcineurin is required for the genesis of bone-resorbing osteoclasts. Year Published: 2007
Mount Sinai Bone Program and Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA.
4. Induction of a program gene expression during osteoblast differentiation with strontium ranelate. Year Published: 2007
Mount Sinai Bone Program, Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA.
5. Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth. Year Published: 2007
Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY 10029, USA.
6. Molecular physiology and pharmacology of calcitonin. Year Published: 2007
Physiological Laboratory, University of Cambridge, Cambridge, UK. clh11@cam.ac.uk
7. Skeletal remodeling in health and disease. Year Published: 2007
The Mount Sinai Bone Program, Department of Medicine, Box 1055, Mount Sinai School of Medicine, New York, New York 10029, USA. mone.zaidi@mssm.edu
8. Regulation of FSH receptor promoter activation in the osteoclast. Year Published: 2007
Mount Sinai Bone Program, Mount Sinai School of Medicine, One Gustave L. Levy Place, NY 10029, USA.
9. The second conference on skeletal medicine and biology: special features. Year Published: 2007
Mount Sinai Bone Program and Department of Medicine, Mount Sinai School of Medicine, New York NY 10029. Mone.zaidi@mssm.edu.
10. Progression of efficacy with ibandronate: a paradigm for the development of new bisphosphonates. Year Published: 2007
Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029. bonedocsol@aol.com.
11. Molecular physiology and pharmacology of calcitonin. Year Published: 2007
Physiological Laboratory, University of Cambridge, Cambridge, UK. clh11@cam.ac.uk
12. Cellular and Molecular Consequences of Calcineurin A{alpha} Gene Deletion. Year Published: 2007
Division of Endocrinology, Box 1055, Mount Sinai School of Medicine, One Gustave Levy Place, New York, NY 10029. li.sun@mssm.edu.
13. The second conference on skeletal medicine and biology: overview and some comments. Year Published: 2007
14. Similarities and contrasts in ryanodine receptor localization and function in osteoclasts and striated muscle cells. Year Published: 2007
Physiological Laboratory, University of Cambridge, Downing Street, Cambridge CB2 3EG, UK. clh11@cam.ac.uk.
15. Proresorptive Actions of FSH and Bone Loss. Year Published: 2007
The Mount Sinai School of Medicine, Division of Endocrinology, Box 1055, One Gustave L. Levy Place, Atran Building AB4-02, New York, NY 10029. Li.sun@mssm.edu.
16. Bone Loss in Thyroid Disease: Role of Low TSH and High Thyroid Hormone. Year Published: 2007
P.O. Box 1055, Mount Sinai School of Medicine, New York, NY 10029. Etsuko.abe@mssm.edu.
17. Functional grouping of osteoclast genes revealed through microarray analysis. Year Published: 2008
Mount Sinai Bone Program, Mount Sinai School of Medicine, New York, NY 10029, USA.
18. Cellular and molecular consequences of calcineurin A alpha gene deletion. Year Published: 2007
Mount Sinai Bone Program and Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA. li.sun@mssm.edu
19. The second conference on skeletal medicine and biology: overview and some comments. Year Published: 2007
20. Similarities and contrasts in ryanodine receptor localization and function in osteoclasts and striated muscle cells. Year Published: 2007
Physiological Laboratory, University of Cambridge, Cambridge, UK. clh11@cam.ac.uk
21. Proresorptive actions of FSH and bone loss. Year Published: 2007
Mount Sinai Bone Program, The Mount Sinai School of Medicine, New York, NY 10029, USA.
22. Bone loss in thyroid disease: role of low TSH and high thyroid hormone. Year Published: 2007
Mount Sinai Bone Program and The Thyroid Research Unit at the James Peter's Veterans Affairs Medical Center, Mount Sinai School of Medicine, New York, NY 10029, USA. Etsuko.abe@mssm.edu
23. Functional grouping of osteoclast genes revealed through microarray analysis. Year Published: 2008
Mount Sinai Bone Program, Mount Sinai School of Medicine, New York, NY 10029, USA.
24. The second conference on skeletal medicine and biology: special features. Year Published: 2007
Mount Sinai Bone Program and Department of Medicine, Mount Sinai School of Medicine, New York NY 10029, USA.
25. Progression of efficacy with ibandronate: a paradigm for the development of new bisphosphonates. Year Published: 2007
The Mount Sinai Bone Program, Mount Sinai School of Medicine, New York, NY 10029, USA.
26. Calcium signalling and calcium transport in bone disease. Year Published: 2008
Department of Pathology, University of Pittsburgh, PA 15261, USA.
27. Acute onset of hematuria and proteinuria associated with multiorgan involvement of the heart, liver, pancreas, kidneys, and skin in a patient with Henoch-Schönlein purpura. Year Published: 2008
1Department of Medicine, Bronx VA Medical Center, Mount Sinai School of Medicine, North Central Bronx Hospital, Bronx, New York, USA.
28. Functional grouping of osteoclast genes revealed through microarray analysis. Year Published: 2008
Mount Sinai Bone Program, Mount Sinai School of Medicine, New York, NY 10029, USA.
29. Calcium signalling and calcium transport in bone disease. Year Published: 2008
Department of Pathology, University of Pittsburgh, PA 15261, USA.
30. The second conference on skeletal medicine and biology: special features. Year Published: 2007
Mount Sinai Bone Program and Department of Medicine, Mount Sinai School of Medicine, New York NY 10029, USA.
31. Progression of efficacy with ibandronate: a paradigm for the development of new bisphosphonates. Year Published: 2007
The Mount Sinai Bone Program, Mount Sinai School of Medicine, New York, NY 10029, USA.
32. Cellular and molecular consequences of calcineurin A alpha gene deletion. Year Published: 2007
Mount Sinai Bone Program and Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA. li.sun@mssm.edu
33. The second conference on skeletal medicine and biology: overview and some comments. Year Published: 2007
34. Similarities and contrasts in ryanodine receptor localization and function in osteoclasts and striated muscle cells. Year Published: 2007
Physiological Laboratory, University of Cambridge, Cambridge, UK. clh11@cam.ac.uk
35. Proresorptive actions of FSH and bone loss. Year Published: 2007
Mount Sinai Bone Program, The Mount Sinai School of Medicine, New York, NY 10029, USA.
36. Bone loss in thyroid disease: role of low TSH and high thyroid hormone. Year Published: 2007
Mount Sinai Bone Program and The Thyroid Research Unit at the James Peter's Veterans Affairs Medical Center, Mount Sinai School of Medicine, New York, NY 10029, USA. Etsuko.abe@mssm.edu
37. Comparative Biodegradation of HDPE and LDPE Using an Indigenously Developed Microbial Consortium. Year Published: 2008
Department of Microbiology, C.B.S.H., G.B. Pant University of Agriculture and Technology, Pantnagar-263145, India.